These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 15023359)
21. Broad-spectrum antiviral activity of PNU-183792, a 4-oxo-dihydroquinoline, against human and animal herpesviruses. Brideau RJ; Knechtel ML; Huang A; Vaillancourt VA; Vera EE; Oien NL; Hopkins TA; Wieber JL; Wilkinson KF; Rush BD; Schwende FJ; Wathen MW Antiviral Res; 2002 Apr; 54(1):19-28. PubMed ID: 11888654 [TBL] [Abstract][Full Text] [Related]
22. Regulatory roles of protein kinases in cytomegalovirus replication. Marschall M; Feichtinger S; Milbradt J Adv Virus Res; 2011; 80():69-101. PubMed ID: 21762822 [TBL] [Abstract][Full Text] [Related]
23. Cytomegalovirus replication and "herpesvirus burden" as risk factor of cardiovascular events in the first year after renal transplantation. Gómez E; Laurés A; Baltar JM; Melón S; Díez B; de Oña M Transplant Proc; 2005 Nov; 37(9):3760-3. PubMed ID: 16386530 [TBL] [Abstract][Full Text] [Related]
24. Lobucavir is phosphorylated in human cytomegalovirus-infected and -uninfected cells and inhibits the viral DNA polymerase. Tenney DJ; Yamanaka G; Voss SM; Cianci CW; Tuomari AV; Sheaffer AK; Alam M; Colonno RJ Antimicrob Agents Chemother; 1997 Dec; 41(12):2680-5. PubMed ID: 9420038 [TBL] [Abstract][Full Text] [Related]
26. Role of the human herpesvirus 6 u69-encoded kinase in the phosphorylation of ganciclovir. De Bolle L; Michel D; Mertens T; Manichanh C; Agut H; De Clercq E; Naesens L Mol Pharmacol; 2002 Sep; 62(3):714-21. PubMed ID: 12181449 [TBL] [Abstract][Full Text] [Related]
27. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2. Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624 [TBL] [Abstract][Full Text] [Related]
28. Effects of maribavir and selected indolocarbazoles on Epstein-Barr virus protein kinase BGLF4 and on viral lytic replication. Gershburg E; Hong K; Pagano JS Antimicrob Agents Chemother; 2004 May; 48(5):1900-3. PubMed ID: 15105156 [TBL] [Abstract][Full Text] [Related]
29. Functional regions of the human cytomegalovirus protein pUL97 involved in nuclear localization and phosphorylation of ganciclovir and pUL97 itself. Michel D; Schaarschmidt P; Wunderlich K; Heuschmid M; Simoncini L; Mühlberger D; Zimmermann A; Pavić I; Mertens T J Gen Virol; 1998 Sep; 79 ( Pt 9)():2105-12. PubMed ID: 9747718 [TBL] [Abstract][Full Text] [Related]
30. (Z)- and (E)-2-(hydroxymethylcyclopropylidene)-methylpurines and pyrimidines as antiviral agents. Qiu YL; Ptak RG; Breitenbach JM; Lin JS; Cheng YC; Kern ER; Drach JC; Zemlicka J Antivir Chem Chemother; 1998 Jul; 9(4):341-52. PubMed ID: 9875413 [TBL] [Abstract][Full Text] [Related]
32. The chemical class of quinazoline compounds provides a core structure for the design of anticytomegaloviral kinase inhibitors. Hutterer C; Hamilton S; Steingruber M; Zeitträger I; Bahsi H; Thuma N; Naing Z; Örfi Z; Örfi L; Socher E; Sticht H; Rawlinson W; Chou S; Haupt VJ; Marschall M Antiviral Res; 2016 Oct; 134():130-143. PubMed ID: 27515131 [TBL] [Abstract][Full Text] [Related]
33. Contrasting effects on ganciclovir susceptibility and replicative capacity of two mutations at codon 466 of the human cytomegalovirus UL97 gene. Martin M; Goyette N; Boivin G J Clin Virol; 2010 Dec; 49(4):296-8. PubMed ID: 20843736 [TBL] [Abstract][Full Text] [Related]
34. Mapping ganciclovir resistance in the human herpesvirus-6 U69 protein kinase. Safronetz D; Petric M; Tellier R; Parvez B; Tipples GA J Med Virol; 2003 Nov; 71(3):434-9. PubMed ID: 12966551 [TBL] [Abstract][Full Text] [Related]
36. Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections. De Clercq E Verh K Acad Geneeskd Belg; 1996; 58(1):19-47; discussion 47-9. PubMed ID: 8701600 [TBL] [Abstract][Full Text] [Related]
37. [Human herpesvirus 6 (HHV-6): incidence in healthy blood donors and in patients with acute infections caused by other herpes viruses]. Larcher C; Huemer HP; Hönlinger M; Margreiter R; Dierich MP Wien Klin Wochenschr; 1989 Jun; 101(13):448-50. PubMed ID: 2548350 [TBL] [Abstract][Full Text] [Related]
38. Antiviral inhibition targeting the HCMV kinase pUL97 requires pUL27-dependent degradation of Tip60 acetyltransferase and cell-cycle arrest. Reitsma JM; Savaryn JP; Faust K; Sato H; Halligan BD; Terhune SS Cell Host Microbe; 2011 Feb; 9(2):103-14. PubMed ID: 21320693 [TBL] [Abstract][Full Text] [Related]
39. Rapid semiquantitative real-time PCR for the detection of human cytomegalovirus UL97 mutations conferring ganciclovir resistance. Göhring K; Mikeler E; Jahn G; Rohde F; Hamprecht K Antivir Ther; 2008; 13(3):461-6. PubMed ID: 18572760 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of herpesvirus replication by a series of 4-oxo-dihydroquinolines with viral polymerase activity. Hartline CB; Harden EA; Williams-Aziz SL; Kushner NL; Brideau RJ; Kern ER Antiviral Res; 2005 Feb; 65(2):97-105. PubMed ID: 15708636 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]